Nasopharyngeal Cancer

Our providers are aware of the newly issued warning from the FDA regarding Singulair (montelukast).  Most patients tolerate this medication well without any adverse symptoms.  However, a small number of patients develop mental health symptoms, including  mood swings, depression, agitation and sleep disturbances.  The symptoms typically resolve shortly after discontinuing the medication. If you think you or your child may be experiencing symptoms related to this medication, our doctors recommend you discontinue using it immediately.  If stopping the medication, a follow up office visit should be scheduled within 1-2 weeks to discuss alternatives. For detailed information, please follow this link to the FDA website:  https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-boxed-warning-about-serious-mental-health-side-effects-asthma-and-allergy-drug

 

Our physicians believe education is a valuable component in the treatment of our patients, and we encourage you to visit the following links.

 

Cancer of the lining of the nasal cavity and throat is known as nasopharyngeal cancer. This cancer usually appears in tandem with a virus affiliated with infectious mononucleosis. Because this cancer frequently spreads to the lymph nodes, it is often diagnosed from of a lump or swelling in the neck. This fast-growing cancer then spreads to the nose, mouth or pharynx, which can cause symptoms such as snoring, nosebleeds or hearing loss. In more advanced cases, the cancer spreads to the lungs, liver and bones of the skull. In addition to surgical removal of the cancerous tissue, this cancer typically requires radiation and/or chemotherapy treatment.